Abstract. 48 patients with a diagnosis of presumptive bacterial conjunctivitis were assessed. They had becn treated with eit her trimethoprim-po[ymyxin or neomycin-po[ ymyxin-gramicidin eye drops in a randomised double-b lind trial. There were 24 patients in each treatment group. There were no sign ificant differences between the two preparat ions with regard to the eradication of organisms or clinical imp rovement, and both preparations proved to be very effective. Pati ent compliance was good and no adverse reactions were encou ntered wi th either preparation.
Introduction
A combination oftrimethoprim and po-[ym yx in would be expected to have significant activit y against most bacterial causes of su rface ocular infection s with the notable excepti on of Neisseria gOl/orrhoea [BlIshb),. 1974 ; Garrod et aI., [9731. Such a combina- tion has also been shown to have liu le potential for producing irritant or allergic reaction s in the eye (unpublished data). It was therefore considered to be of clinical interest to test the effcct oftrimethoprim-po[ymyx in (TP) against an established eye preparation containing neom ycin-polym yx in-gramicidin (N PG) in the treatment of surface ocular bacterial infections.
Subjects and Methods
T P and NPG ophthalmic solutions were supplied by Deutsche Wellcome.
Patients aged bet ween 8 and 80 inclusive, al\cnding the Augenklinik in Brnunsc hweig. with a presumptive diagnosis of surface ocular bacterial infcction. weTC entered into the trial with the following exclusions:
(i) Those who had received treatment with oth creyc prcparntions or systcmi c antibiotics within the 72 h prior to the commenccment of the trial.
(ii) Those who had concomitant fungus. virus or tuberculous infections of thc C)'c.
(iii) Those who required concurrent treatment with a systemic or local corticosteroid. antihistamine and/or antibiotic.
(iv) Those who had previously demonstrated allergic hypersensitivity to trimethoprim. polymyxin B. neomycin or gramicidin.
(v) Those who had contracted more than four infectionsofthe external eye with th e duration of one of these inkctions being longer than 2 weeks during the 12 months priorto being considered for admission into the trial.
Although the admission criteria could theoretically have allowed the entry of patients with a wider spec· trum of disease processes. in fact all the patients entered had presumptive bacterial conjunctivitis. Informed consent was obtained in all cases and the patients wcre fully assessed clinically at the initial visit and at two follow-up appointments -one approximately 5-6 days after the start of therapy and the second follow-up approximately 12 -15 days after the stan of therapy.
Symptoms and signs were graded on a 0 -J scale (where 0", not present; I", mild; 2 '" moderate; 3 =: severe). In addition. a colour photograph of the affected eye or eyes was taken \0 allow for independent assessment also using a 0 -3 grading system (where 0 =: normal. I '" slight. diffuse or localised redness: 2 '" generalised redne,s; 3", generalised redness and redness and swelling of the eyelids).
Swabs for bacteriological assessment were taken from the lower conjunctival sac at each visit and these were directly pialcd onto blood agar and the plates incubated at 37 'c. In the latter part ofthc study. chocolatc agar culture medium was used in addition to blood agar in order \0 enhance th e possibility of culturing Haemophilus spceies. Smears of material from the lower conjunctival sac swabbing were also examined by direct microscopy.
The patients were allocated to one or other treatment in a randomised manner and the trial was conducted in a double-blind fashion. The dosage of either preparation was onc drop into each affected eye six limes daily for 10 days and thc patients completed a record card 10 aid compliance.
Results
Of66 patients enrolled into the trial , only 48 could be fully evaluated. These were 93 equally divided between the two treat ment groups.
The other 18 patients were excluded for the follow ing reasons: failure to attend for fo llow-up visits (8 patients), proven viral infection (3 patients). poor compliance with the treatment regime (this is taken to mean the use orJess than forty doses per treatment course-6 patients) and inadequate information (1 patient).
The bacteriological results are shown in table I. Bacteria were isolated from the pretreatment swabs of 14 of the patients treated with NPG and 8 treated with T P. Bacteria were erad ica ted in all except 2 of the patients receiving NPG. In I case, Staphylococclls epidermidis was still isolated following treatment and in another, Streptococclis Ilirida/ls. isolated on entry to the trial, was replaced by Klebsieila oceallae following treatment. However, in both these patients, signs and symptoms com pletely disappeared following treatment. In the 8 patients receiving TP from whom bacteria were cultured initially, bacteria were eradicated in all the cases following treatment. However, the initial swab from I patient in the TP group failed to grow an organism whereas the posttherapy culture grew Streptococcl/S viridal/ s. although the patient's signs and symptoms had improved following treatment.
Swabs from the remaining 25 patients fa iled to grow any organisms. In nearly all the cases, however (42 out of lhe 48),leucocytes were found in the pre-treatment smears.
It will be seen from table I that man y of the organisms grown are traditionally regarded as being non-pathogen ic but it would appear that they may be pathogenic in the eye and elsewhere under certain circumstances [Jarl/di et a1. , 1975; MUI/I'o. 1981] . The signs and symptoms which were assessed are indicated in table II . For the purpose of statistical analysis, signs and symptoms recorded on the patient record form were in some instances grouped together (see ered as data from a spl it plot design and subjected to analysis of variance: subject, occasion and treatment effects were thus examined simultaneously. Further investigat ion was carried out by Duncan multiple range test ifand when significant differences were demonstrated.
In all cases, significant (p < O.OS) occasion differences were revealed. There was no significant difference between the treatment groups either before treatment or at either fo llow-up visi!. Mean scores for single or grouped signs and symptoms are shown in table II I.
Photographic data from the two groups were examined by analysis of variance. Diffe rences between the treatment grOllps did not ach ieve significance either prior to or effective both clin ically and bacteriologically. Improvement of signs and symptoms and erad ication of pathogens was found to be good with both combinations. No side effects were observed with either preparation and good compliance was found in this st udy, especially considering that the drops were used six times a day for 10 days. The rate of isolation of pathogenic organ· isms was found to be low. In only 22 of the 48 patients (46%) was an organism isolated from the swab taken prior to therapy and this includes isolation of S. epidermidis and S. viridans. It must be borne in mind, however, that some authorities regard these organisms as pathogenic in the eye in certain circumstances. It would appear that many cases diagnosed as presumptive bacterial conj unc· tiv it is either have so me other cause for their conjunctivitis or there is a failure of the clini· cian's ability to isolate the bacterial organ· isms responsible. Statements by various au· t hors would appear to give support to this vicw [Jomdi el a l. . 1975; .f,.-tiller. 19781 
